| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |